Robertson Stephens Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.65M Sell
52,607
-11
-0% -$1.45K 0.16% 106
2026
Q1
$7.33M Buy
52,618
+1,573
+3% +$220K 0.21% 97
2025
Q4
$6.27M Buy
51,045
+47,885
+1,515% +$5.82M 0.16% 109
2025
Q3
$351K Sell
3,160
-228
-7% -$25.9K 0.01% 419
2025
Q2
$376K Sell
3,388
-32
-0.9% -$3.41K 0.01% 423
2025
Q1
$383K Sell
3,420
-292
-8% -$30.1K 0.01% 405
2024
Q4
$343K Buy
3,712
+83
+2% +$7.47K 0.01% 437
2024
Q3
$304K Sell
3,629
-446
-11% -$34K 0.01% 521
2024
Q2
$280K Sell
4,075
-1,427
-26% -$95.2K 0.01% 426
2024
Q1
$403K Buy
5,502
+153
+3% +$11.8K 0.02% 381
2023
Q4
$433K Buy
5,349
+1,310
+32% +$102K 0.03% 334
2023
Q3
$303K Sell
4,039
-182
-4% -$14K 0.02% 372
2023
Q2
$325K Sell
4,221
-690
-14% -$55K 0.02% 342
2023
Q1
$407K Buy
4,911
+366
+8% +$30.3K 0.03% 319
2022
Q4
$390K Sell
4,545
-162
-3% -$12.8K 0.04% 292
2022
Q3
$290K Sell
4,707
-1,409
-23% -$88.8K 0.03% 283
2022
Q2
$378K Buy
6,116
+2,580
+73% +$160K 0.04% 272
2022
Q1
$210K Buy
3,536
+11
+0.3% +$703 0.02% 366
2021
Q4
$255K Buy
+3,525
New +$243K 0.02% 342
2021
Q2
– Sell
-4,097
Closed -$264K – 338
2021
Q1
$264K Buy
+4,097
New +$264K 0.04% 250

Other funds holding GILD

Robertson Stephens Wealth Management's GILD Position: Q2 2026 in Review

Robertson Stephens Wealth Management reduced its Gilead Sciences (GILD) stake by 0.02% in Q2 2026, selling an estimated $1.45K and leaving 52,607 shares worth $6.65M. The position accounts for 0.16% of the portfolio, ranked #106.

Robertson Stephens Wealth Management first reported a position in GILD in Q1 2021 and has held it in 20 quarters since. The position peaked at $7.33M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Robertson Stephens Wealth Management held 52,607 shares of Gilead Sciences worth $6.65M as of Q2 2026.
  • Robertson Stephens Wealth Management sold 11 Gilead Sciences shares in Q2 2026, an estimated $1.45K.
  • Gilead Sciences made up 0.16% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #106 holding.
  • Robertson Stephens Wealth Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 20 quarters since.
  • Robertson Stephens Wealth Management's Gilead Sciences position peaked at $7.33M in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.